O'Connor Donal

2.3

2.3

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Glanbia PLC (GL9)

Transaction date 20 Aug 2024

Purchase

Price

283.68

Quantity 49,659

Value €2,175,174

Theravance Biopharma Inc (TBPH)

Transaction date 17 May 2019

Sale

Price

263.99

Quantity 39,763 +26.7%

Value US$3,350,581

Comments Filing

Theravance Biopharma Inc (TBPH)

Transaction date 16 May 2019

Sale

Price

411.58

Quantity 21,500 -31.6%

Value US$3,971,972

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2024-08-21	2024-08-20	Glanbia PLC (GL9)	B Purchase	49,659 283.68 €2,175,174	49,659	283.68	€2,175,174
2019-05-20	2019-05-17	Theravance Biopharma Inc (TBPH)	S Sale	39,763 +26.7% 263.99 US$3,350,581	39,763 +26.7%	263.99	US$3,350,581
2019-05-20	2019-05-16	Theravance Biopharma Inc (TBPH)	S Sale	21,500 -31.6% 411.58 US$3,971,972	21,500 -31.6%	411.58	US$3,971,972